PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Successful Completion of Entitlement Offer, page-90

  1. 832 Posts.
    lightbulb Created with Sketch. 331
    PR taking his allocation in the CR was a good sign from him that all is well long term. I think the DM will be positive but I can't see it sending us north alot. It may take us back towards the $1.80 range. I think the story is.. Fully funded through to 2024 (hopefully), a deal for MPS happens and we start seeing some good traction out of 003, I think it is 002 that will provide the planks upward based on results and ultimately gets FDA / BP moving. Time and cash burn is our enemy, personally I dont think efficacy is an issue.

    Poolboy
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.